183 related articles for article (PubMed ID: 14660277)
1. Cytochemical and ultrastructural changes in the osteoclast-like giant cells of giant cell tumor of bone following bisphosphonate administration.
Cheng YY; Huang L; Kumta SM; Lee KM; Lai FM; Tam JS
Ultrastruct Pathol; 2003; 27(6):385-91. PubMed ID: 14660277
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM
Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis of osteoclast-like cells induced by alendronate is related to Fas gene expression.
Wang XM; Yu SF; Yang ZP
Chin J Dent Res; 2000 Aug; 3(2):26-32. PubMed ID: 11314515
[TBL] [Abstract][Full Text] [Related]
4. Pamidronate, farnesyl transferase, and geranylgeranyl transferase-I inhibitors affects cell proliferation, apoptosis, and OPG/RANKL mRNA expression in stromal cells of giant cell tumor of bone.
Lau CP; Huang L; Tsui SK; Ng PK; Leung PY; Kumta SM
J Orthop Res; 2011 Mar; 29(3):403-13. PubMed ID: 20886653
[TBL] [Abstract][Full Text] [Related]
5. Thapsigargin potentiates TRAIL-induced apoptosis in giant cell tumor of bone.
Huang L; Xu J; Li K; Zheng MH; Kumta SM
Bone; 2004 Jun; 34(6):971-81. PubMed ID: 15193543
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone.
Mak IW; Seidlitz EP; Cowan RW; Turcotte RE; Popovic S; Wu WC; Singh G; Ghert M
Hum Pathol; 2010 Sep; 41(9):1320-9. PubMed ID: 20573369
[TBL] [Abstract][Full Text] [Related]
7. Presence of leukaemia inhibitory factor (LIF) and LIF-receptor chain (gp190) in osteoclast-like cells cultured from human giant cell tumour of bone. Ultrastructural distribution.
Gouin F; Couillaud S; Cottrel M; Godard A; Passuti N; Heymann D
Cytokine; 1999 Apr; 11(4):282-9. PubMed ID: 10328867
[TBL] [Abstract][Full Text] [Related]
8. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone.
Liao TS; Yurgelun MB; Chang SS; Zhang HZ; Murakami K; Blaine TA; Parisien MV; Kim W; Winchester RJ; Lee FY
J Orthop Res; 2005 Jan; 23(1):203-9. PubMed ID: 15607894
[TBL] [Abstract][Full Text] [Related]
11. Expression of bone morphogenetic proteins in giant cell tumor of bone.
Kudo N; Ogose A; Ariizumi T; Kawashima H; Hotta T; Hatano H; Morita T; Nagata M; Siki Y; Kawai A; Hotta Y; Hoshino M; Endo N
Anticancer Res; 2009 Jun; 29(6):2219-25. PubMed ID: 19528484
[TBL] [Abstract][Full Text] [Related]
12. Binuclear cells induced by acridine orange in giant cell tumor of bone.
Kusuzaki K; Takeshita H; Murata H; Hashiguchi S; Nozaki T; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(5A):3013-7. PubMed ID: 11062716
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study.
Tse LF; Wong KC; Kumta SM; Huang L; Chow TC; Griffith JF
Bone; 2008 Jan; 42(1):68-73. PubMed ID: 17962092
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
15. Locally administered zoledronic Acid therapy for giant cell tumor of bone.
Nishisho T; Hanaoka N; Endo K; Takahashi M; Yasui N
Orthopedics; 2011 Jul; 34(7):e312-5. PubMed ID: 21717996
[TBL] [Abstract][Full Text] [Related]
16. Giant cell tumor of bone: analysis of proliferative cells by double-labeling immunohistochemistry with anti-proliferating cell nuclear antigen antibody and culture procedure.
Abe Y; Yonemura K; Nishida K; Takagi K
Nihon Seikeigeka Gakkai Zasshi; 1994 May; 68(5):407-14. PubMed ID: 7914219
[TBL] [Abstract][Full Text] [Related]
17. Contrast study on multinucleated giant cells in giant cell tumors of bone and other multinucleated cells.
Zhou L; Feng CH; Li HP
Chin Med J (Engl); 1989 Aug; 102(8):584-90. PubMed ID: 2517613
[TBL] [Abstract][Full Text] [Related]
18. Pamidronate decreases tumor-induced osteoclastogenesis in osteopetrotic mice.
Clohisy DR; O' Keefe PF; Ramnaraine ML
J Orthop Res; 2001 Jul; 19(4):554-8. PubMed ID: 11518261
[TBL] [Abstract][Full Text] [Related]
19. Giant cell tumors of bone.
Roux S
Rev Rhum Engl Ed; 1998 Feb; 65(2):139-47. PubMed ID: 9540123
[TBL] [Abstract][Full Text] [Related]
20. [Multinucleated giant cells in cultured giant cell tumor of bone].
Zhou L
Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):689-91, 703. PubMed ID: 2632204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
